Segmentation & Volumetrics Report
Detailed volumes of tumor regions are provided in comprehensive reports and automatically routed to PACS for seamless integration into your workflow.
AI Neurology & Neuro-Oncology
NeuroQuant® Brain Tumor
Clearer Insights into MS Lesions
NeuroQuant® Brain Tumor
FDA-Cleared Software for Advanced Brain Tumor Analysis
Powered by AI, NeuroQuant® Brain Tumor provides objective tumor measurements and analysis of changes over time, supporting radiologists, oncologists, neurosurgeons, and multidisciplinary tumor boards in their clinical assessments.
Comprehensive Brain Tumor Assessment
MRI Sequences: T1 Pre/Post, T2 & T2 FLAIR
Glioma Segmentation
Support clinical assessment with objective volumetric data and color-coded brain structure images to inform diagnosis, treatment, and lifestyle planning. Assess lesion dissemination and distribution patterns, identify areas with the greatest lesion burden, and track lesions across orthogonal views.
Requires T1 Pre- and Post-Contrast Images
Meningioma Segmentation
Designed for single- and multiple-timepoint studies, this module classifies brain metastases and tracks changes over time, identifying new, enlarging, shrinking, stable, and resolved lesions. Comprehensive results include lesion counts, individual and total lesion volumes, and precise locations.
Required MRI Sequences: T1 Pre- and Post-Contrast
Meningioma Segmentation
Supports meningioma analysis across single and multiple timepoints, segmenting the necrotic core and enhancing tissue. Detailed volumetric measurements enable comparison of current and prior studies and assessment of changes over time.
Objective Tumor Insights Made Simple
Longitudinal Analysis
Prior studies of the same patients are automatically included on reports for precise volumetric comparison over time, enabling better treatment monitoring.
Tumor Segmentation Color Overlay Series
Slice-by-slice tumor segmentations are routed to PACS with tumor regions of interest color coded for easy viewing and interpretation.
RT STRUCT
Advanced contour generation that can be manipulated for treatment planning, surgical planning, and radiation oncology applications.
NeuroQuant®
Brain Tumor Benefits
Enhanced Objectivity & Reproducibility
Quantitative brain tumor volumetrics provide more objectivity and are more reproducible than 2D visual analyses 1
¹ Blomstergen et al., (2018, July)
Time-Series Analysis
Displays time-series data for tumor volumes across multiple scans, allowing for better comparison and treatment planning
Comprehensive Tumor Coverage
Supports the analysis of gliomas, metastases, and meningiomas, offering broader clinical utility than solutions limited to one tumor type
Reports
Brain Tumor Reports
Comprehensive segmentation and volumetric reports, automatically delivered to PACS for seamless workflow integration.
Glioma Volumetric Assessment Report
The NeuroQuant® Glioma Quantification Report identifies and measures total lesion volume, including enhancing and non-enhancing components, to support consistent monitoring of low- and high-grade gliomas over time.
Metastasis Quantification Report
The NeuroQuant® Brain Tumor Metastasis Report detects, measures, and tracks lesions over time, highlighting new, resolved, shrinking, and enlarging tumors to simplify interpretation and support clinical decision-making.
Meningioma Quantification Report
The NeuroQuant® Brain Tumor Meningioma Report provides precise segmentation and volumetric measurement of enhancing tumor tissue and the necrotic core, supporting consistent assessment of tumor progression and treatment response over time.
Take the next step
NeuroQuant® Brain Tumor
FDA-cleared software for advanced brain tumor analyses
Powered by AI, NeuroQuant® Brain Tumor assists radiologists, oncologists, neurosurgeons, and the Tumor Board by providing objective quantification and analysis of tumor changes over time.
Request a demoLet’s discuss your brain tumor imaging workflow.
